ConductScience.org, home

Gene · 683

Papers2,228

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans.Nat Metab202641540253PubTator, text miningPubMed
Proteomic and Genetic Insights into Ancestry-Specific Associations in Parkinson's Disease.Mov Disord202641504309PubTator, text miningPubMed
Integrative transcriptomic analysis identifies an oxidative stress-associated diagnostic signature for myocardial infarction.J Thromb Thrombolysis202641222888PubTator, text miningPubMed
Distinct endothelial cells in chronic thromboembolic pulmonary hypertension.NPJ Cardiovasc Health202541776006PubTator, text miningPubMed
Cross-Regional Transcriptome Data Reveal Transcriptional Abnormalities Associated with Lung Adenocarcinoma.Rep Biochem Mol Biol202541531656PubTator, text miningPubMed
Pathological Mechanisms in Sjögren's Disease Likely Involve the ADP-Ribosyl Cyclase Family Members: CD38 and CD157.Int J Mol Sci202541373701PubTator, text miningPubMed
Development and validation of a prognostic prediction model for gastric cancer based on lipophagy-related genes.Transl Cancer Res202541245802PubTator, text miningPubMed
Follicular helper T cells (Tfh): heterogeneity in spatial distribution and phenotypic characteristics.Front Immunol202541181158PubTator, text miningPubMed
Neutrophil extracellular trap-related signature predicts the prognosis and immunotherapy outcome of lung adenocarcinoma.Genomics202541135717PubTator, text miningPubMed
Elucidate biomarkers and the molecular pathways associated with genetic variants that contribute to the etiology of Parkinson's disease.Acta Neurol Belg202541026459PubTator, text miningPubMed
The LRRK2 p.A419V variant associates with risk of Parkinson's disease in the East Asian population and an evaluation on age of onset.medRxiv202540950508PubTator, text miningPubMed
Exploring potential target drugs for vision-threatening diabetic retinopathy using the human plasma proteome: a Mendelian randomisation study.BMJ Open202540935427PubTator, text miningPubMed
Discovery and early validation of serum protein signatures in untreated multiple sclerosis patients: identification of candidate biomarkers for diagnosis and stratification.Front Immunol202540918143PubTator, text miningPubMed
Associations between NETosis-related genes and 28-day mortality in patients with sepsis: An observational retrospective study and bioinformatic analysis.Sci Prog202540888582PubTator, text miningPubMed
Ultrahigh thermoelectricity obtained in classical BiSbTe alloy processed under super-gravity.Nat Commun202540818966PubTator, text miningPubMed
EFFECTS OF HYPERBARIC, HYPEROXIA, PRESSURE AND HYPOXIA ON CD38 AND CD157 EXPRESSION IN ISOLATED PERIPHERAL BLOOD MONOCYTES: IN VITRO STUDY.Georgian Med News202540694712PubTator, text miningPubMed
Bioinformatics analysis identifies BST1 as a potential therapeutic target linked to neutrophil extracellular traps in patients with acute liver failure.Sci Rep202540628837PubTator, text miningPubMed
Comprehensive analysis and experimental validation of BST1 as a novel diagnostic biomarker for pediatric sepsis using multiple machine learning algorithms.Eur J Pediatr202540555937PubTator, text miningPubMed
Deciphering the role of nicotinamide metabolism and melanin-related genes in acute myocardial infarction: a machine learning approach integrating bioinformatics analysis.Korean J Physiol Pharmacol202540415653PubTator, text miningPubMed
Human endothelial colony forming cells (ECFCs) require endothelial protein C receptor (EPCR) for cell cycle progression and angiogenic activity.Angiogenesis202540407837PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/683/papers?page=2